Cargando…

Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532463/
http://dx.doi.org/10.1007/s40278-021-03978-1
_version_ 1784587075312418816
collection PubMed
description
format Online
Article
Text
id pubmed-8532463
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85324632021-10-22 Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel Reactions Weekly Clinical Study Springer International Publishing 2021-10-23 2021 /pmc/articles/PMC8532463/ http://dx.doi.org/10.1007/s40278-021-03978-1 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
title Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
title_full Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
title_fullStr Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
title_full_unstemmed Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
title_short Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
title_sort myocarditis with pfizer-biontech's covid-19 vaccine in israel
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532463/
http://dx.doi.org/10.1007/s40278-021-03978-1